ghk-cu clinical trial wound healing randomized double blind Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with Peripheral Neuropathy: Vitamin B12 Qty:3 vials made_in_usa
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19